Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Classifica tra le azioni #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Prezzo delle azioni
$62.83
Capitalizzazione di mercato
$93.23B
Variazione (1 giorno)
-9.17%
Variazione (1 anno)
-31.36%
Paese
US
Scambia Boston Scientific Corporation (BSX)

Categoria

Utile per Boston Scientific Corporation (BSX)
Utile nel Dec 2025 TTM: $3.39B
Secondo gli ultimi rapporti finanziari di Boston Scientific Corporation, gli utili attuali della società sono $3.39B. Nel 2024, la società ha registrato un utile di $2.28B, un aumento rispetto a agli utili del 2023, che erano di $1.99B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Boston Scientific Corporation dal 2000 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $3.39B 0.00%
2025 $3.39B 48.33%
2024 $2.28B 14.96%
2023 $1.99B 73.97%
2022 $1.14B 6.04%
2021 $1.08B -1,462.03%
2020 $-79.00M -111.50%
2019 $687.00M -51.69%
2018 $1.42B 52.41%
2017 $933.00M 427.12%
2016 $177.00M -127.23%
2015 $-650.00M 27.70%
2014 $-509.00M 128.25%
2013 $-223.00M -94.57%
2012 $-4.11B -739.72%
2011 $642.00M -160.40%
2010 $-1.06B -18.73%
2009 $-1.31B -35.60%
2008 $-2.03B 256.94%
2007 $-569.00M -83.90%
2006 $-3.54B -496.75%
2005 $891.00M -40.36%
2004 $1.49B 132.35%
2003 $643.00M 17.12%
2002 $549.00M 1,147.73%
2001 $44.00M -91.65%
2000 $527.00M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$8.47B 150.10%
US
$4.51B 33.35%
US
$5.56B 64.38%
IE
$5.56B 64.34%
IE
$3.13B -7.48%
DE